HypertensionCross-sectional study

Hypertension awareness, treatment, and control in coronary heart disease patients: results of the EUROASPIRE V survey conducted in 27 countries

Eur J Prev CardiolPublished

  • Cross-sectional study
  • multinational survey
  • 27 countries

Authors' conclusion

Hypertension control remains poor in hypertensive CHD patients, despite high treatment and reasonable awareness levels.

Study context

Population
Patients with coronary heart disease (CHD) and hypertension, EUROASPIRE V survey6,496 hypertensive
Participants
8,261 patients
Outcome
Hypertension awareness, treatment and control (BP <140/90 mmHg; <140/85 mmHg with diabetes)

Main finding

As reported in the abstract

Hypertension awareness, treatment and control

Aware

60.4%

On treatment

91.7%

Controlled

46.8%

Observational data: associations, not effects.

Further findings

Factors associated with awareness

ComparisonOR (95% CI)
Number of antihypertensive drugs1.23 (1.16–1.31)
Adherence2.18 (1.74–2.74)
Secondary education1.32 (1.03–1.68)
Tertiary education1.70 (1.32–2.17)
Lifestyle changes1.60 (1.37–1.87)

Factors associated with blood pressure (BP) control

ComparisonOR (95% CI)
Number of antihypertensive drugs · controlled vs uncontrolled patients1.11 (1.05–1.17)
Adherence · controlled vs uncontrolled patients1.93 (1.57–2.37)
Aware · controlled vs uncontrolled patients1.43 (1.23–1.65)
BMI >25kg/m² · controlled vs uncontrolled patients0.73 (0.61–0.87)
Diabetes · controlled vs uncontrolled patients0.67 (0.59–0.76)
LDL ≥1.8mmol/L · controlled vs uncontrolled patients0.75 (0.65–0.86)

Original publication

Hypertension awareness, treatment, and control in coronary heart disease patients: results of the EUROASPIRE V survey conducted in 27 countries. Eur J Prev Cardiol. Published 29 July 2026. doi:10.1093/eurjpc/zwag377

Summarised from the published abstract; every number is checked against it